UNSPSC 85815619: Introduction of oxazolidinones into central vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into central vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E04028

UNSPSC 85815619, Introduction of oxazolidinones into central vein, open approach, is a Commodity code that shows minimal alignment with recent state and local procurement activity. The UNSPSC nomenclature—a clinical procedure code—does not match the scope of any opportunities posted under this classification in the recent market sample. State and local governments are not soliciting for the performance of this specific procedure or medication administration approach through public procurement channels.

The four opportunities tagged to this code reflect a mismatch: Inland Empire Health Plan's virtual urgent care RFI (Oct 16, 2026), DeKalb County's generic medical services contract (Oct 12, 2026), Nevada Health Authority's PACE program (Oct 8, 2026), and Nevada's Rural Value Acceleration Network vendor search (Oct 7, 2026) all pursue broader telehealth, integrated care, or managed long-term services delivery rather than central venous access procedures. The code appears to have been assigned in error or used as a classification catch-all by issuing bodies unfamiliar with procedure-specific UNSPSC taxonomy. There is no meaningful recent activity under this code that reflects the narrow clinical scope of the taxonomy term itself.